Ma M - Search Results

1

Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapies.

Wu B, Melara R, Rasmussen E, Zhou L, Wong T, Kitahara C, Ma M, Lu J, Gamelin E, Pickett CA, Sun YN. Wu B, et al. Among authors: ma m. Cancer Chemother Pharmacol. 2015 Aug;76(2):243-50. doi: 10.1007/s00280-015-2748-1. Epub 2015 Jun 2. Cancer Chemother Pharmacol. 2015. PMID: 26032239 Review.

2

Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins.

Kathman S Jr, Thway TM, Zhou L, Lee S, Yu S, Ma M, Chirmule N, Jawa V. Kathman S Jr, et al. Among authors: ma m. AAPS J. 2016 Mar;18(2):424-31. doi: 10.1208/s12248-015-9853-2. Epub 2016 Jan 19. AAPS J. 2016. PMID: 26786568 Free PMC article.

3

Impact of anti-drug antibodies in preclinical pharmacokinetic assessment.

Thway TM, Magana I, Bautista A, Jawa V, Gu W, Ma M. Thway TM, et al. Among authors: ma m. AAPS J. 2013 Jul;15(3):856-63. doi: 10.1208/s12248-013-9484-4. Epub 2013 May 8. AAPS J. 2013. PMID: 23653044 Free PMC article.

4

Indirect assessment of neutralizing anti-drug antibodies utilizing pharmacokinetic assay data.

Vettermann C, Ortiz J, Lee S, Sanchez S, Victor HP, Ma M, Heath T, Gupta S. Vettermann C, et al. Among authors: ma m. J Immunol Methods. 2016 Feb;429:28-38. doi: 10.1016/j.jim.2015.12.010. Epub 2015 Dec 19. J Immunol Methods. 2016. PMID: 26711311

5

Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromolecules.

Thway TM, Macaraeg CR, Calamba D, Brunner LA, Eschenberg M, Pourvasei R, Zhang L, Ma M, Desilva B. Thway TM, et al. Among authors: ma m. Bioanalysis. 2010 Sep;2(9):1587-96. doi: 10.4155/bio.10.75. Bioanalysis. 2010. PMID: 21083287

6

Experimental and statistical approaches in method cross-validation to support pharmacokinetic decisions.

Thway TM, Ma M, Lee J, Sloey B, Yu S, Wang YM, Desilva B, Graves T. Thway TM, et al. Among authors: ma m. J Pharm Biomed Anal. 2009 Apr 5;49(3):613-8. doi: 10.1016/j.jpba.2008.12.008. Epub 2008 Dec 13. J Pharm Biomed Anal. 2009. PMID: 19150189

7

In Silico Evaluation of the Potential Impact of Bioanalytical Bias Difference between Two Therapeutic Protein Formulations for Pharmacokinetic Assessment in a Biocomparability Study.

Thway TM, Macaraeg C, Eschenberg M, Ma M. Thway TM, et al. Among authors: ma m. AAPS J. 2015 May;17(3):684-90. doi: 10.1208/s12248-015-9741-9. Epub 2015 Mar 5. AAPS J. 2015. PMID: 25739817 Free PMC article. Clinical Trial.

8

Pharmacokinetics and safety of a fully human hepatocyte growth factor antibody, AMG 102, in cynomolgus monkeys.

Kakkar T, Ma M, Zhuang Y, Patton A, Hu Z, Mounho B. Kakkar T, et al. Among authors: ma m. Pharm Res. 2007 Oct;24(10):1910-8. doi: 10.1007/s11095-007-9316-2. Epub 2007 May 23. Pharm Res. 2007. PMID: 17520181

9

Implementation of a universal analytical method in early-stage development of human antibody therapeutics: application to pharmacokinetic assessment for candidate selection.

Shih JY, Patel V, Watson A, Hager T, Luan P, Salimi-Moosavi H, Ma M. Shih JY, et al. Among authors: ma m. Bioanalysis. 2012 Oct;4(19):2357-65. doi: 10.4155/bio.12.201. Bioanalysis. 2012. PMID: 23088462

10

Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform.

Talbot JJ, Calamba D, Pai M, Ma M, Thway TM. Talbot JJ, et al. Among authors: ma m. AAPS J. 2015 Nov;17(6):1446-54. doi: 10.1208/s12248-015-9807-8. Epub 2015 Aug 12. AAPS J. 2015. PMID: 26265093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,771 results

Search Page

Filters